Home

Ra Capital Management reported a 0% stake in Dyne Therapeutics DYN · 0 sh · amendment · passive holder

Trade details

Type
5% stake report
Report
13G passive · amendment
Stake
0%
Last report
8.5% · filed 25/05/15
Shares held
0 sh
Class
Common Stock, $0.0001 par value per share
Event date
25/09/30
Filed
25/11/14

0% stake · fully exited

Stake
0%
Last report
8.5%
Since last report
−8.5pp

Dyne Therapeutics trades, last 26 weeks

What else happened in Dyne Therapeutics around then

Filed or reported within 30 days of the trade day · 25/08/31~25/10/30

Ra Capital Management's other 5% stake reports

  • Ra Capital Management

    5% stakeCorbus Pharmaceuticals Holdings

    9.9% stake

    Filed 09/30

  • Ra Capital Management

    5% stakeBetterLife Pharma

    9% stake

    Filed 09/22

  • Ra Capital Management

    5% stakeSionna Therapeutics

    14.3% stake

    Filed 09/21

  • Ra Capital Management

    5% stakeTyra Biosciences

    19.9% stake

    Filed 09/17

  • Ra Capital Management

    5% stakeJatt III Acquisition

    5.1% stake

    Filed 09/03

Ra Capital Management reported a 0% stake in Dyne Therapeutics DYN · 0 sh · amendment · passive holder | Whalegun